Novela Neurotech
Novela Neurotech develops the Neureka® epilepsy care platform, integrating FDA-cleared wearable technology (SeizureLink™ and SPEAC®) for continuous seizure monitoring, serving epilepsy patients and neurology healthcare providers in the United States.
- Company typePrivate
- Founded2018
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Novela Neurotech firmographics
Firmographics- Name
- Novela Neurotech
- Legal name
- Novela Neurotechnologies Inc.
- Website
- https://neureka.ai
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Novela Neurotech develops the Neureka® epilepsy care platform, integrating FDA-cleared wearable technology (SeizureLink™ and SPEAC®) for continuous seizure monitoring, serving epilepsy patients and neurology healthcare providers in the United States.
- Ownership category
- akta.pro rank
Novela Neurotech industry classification
Industry- Product category
- Epilepsy Care Technology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Neurology Telemedicine Platforms (HLALAGAC), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Epilepsy & Seizure Disorders (HLAKAIAB)
Keywords
Where Novela Neurotech is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Novela Neurotech business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Novela Neurotech product offering
Product offeringCore offering
Novela Neurotech develops and operates the Neureka® epilepsy care platform, which delivers continuous seizure monitoring and diagnostic support using FDA-cleared wearable technology. The company sells the SeizureLink™ wearable and the SPEAC® System—both acquired through the 2022 Brain Sentinel IP acquisition—as integrated components of its platform for epilepsy diagnosis and seizure detection.
Differentiator
Problem solved
Functional benefit
Brands
- Neureka®: Epilepsy care platform developed by Novela Neurotechnologies for seizure diagnosis and detection through FDA-cleared wearables.
- SeizureLink™
- SPEAC® System
Products and services
- Neureka® Flagship epilepsy care platform from Novela Neurotech providing continuous monitoring and seizure detection through FDA-cleared wearable technology, intended for use by healthcare providers managing epilepsy patients.
- SeizureLink™ Wearable Wearable device for seizure detection and monitoring, acquired as part of the Brain Sentinel Inc. intellectual property portfolio and integrated into Novela's Neureka® epilepsy care platform for continuous monitoring.
- SPEAC® System FDA-cleared seizure monitoring system acquired from Brain Sentinel Inc. and integrated into Novela's Neureka® epilepsy care platform to enhance diagnostic and continuous monitoring capabilities.
Companies that use Novela Neurotech
Customer profileSegments2 records
Ideal customer profiles2 records
Novela Neurotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature3 records
Novela Neurotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Brain Sentinel Inc.coreNovela Neurotechnologies Inc. acquired the intellectual property of Brain Sentinel Inc., including patents and the SeizureLink™ wearable and SPEAC® System. This acquisition was made to advance Novela's epilepsy care platform Neureka®, enhancing the company's ability to diagnose and detect seizures through FDA-cleared wearables that provide continuous monitoring.
Novela Neurotech competitors and assessment
Company assessmentDirect peers
- Empatica: Empatica makes the EpiMonitor (formerly Embrace2) wearable, an FDA-cleared smartwatch for seizure detection in epilepsy patients. It is the most direct functional peer to Novela's SeizureLink/SPEAC wearable-monitor approach and competes for the same neurologist-prescribed channel.
- NeuroPace: NeuroPace commercializes the RNS® System, a closed-loop neurostimulator that continuously monitors and responds to seizure activity. While implantable rather than wearable, NeuroPace addresses the same refractory-epilepsy population and competes for neurology share-of-mind and reimbursement.
Emerging players
- Epitel: Epitel develops wearable, point-of-care and long-term EEG sensors (e.g., the Epitel patch) for seizure detection and monitoring. Its wireless, disposable EEG patch overlaps directly with Novela's continuous-monitoring value proposition in ambulatory epilepsy care.
- UNEEG Medical: UNEEG produces the 24/7 EEG™ SubQ subcutaneous EEG implant for long-term seizure monitoring in epilepsy. It overlaps with Novela on the continuous-EEG-monitoring use case for refractory epilepsy patients.
- iMediSync: iMediSync develops AI-enabled EEG analysis tools and wearable brain-mapping hardware. Its overlap is in the intersection of EEG hardware and AI-driven seizure/neurology analytics, paralleling Novela's wearable-plus-software platform approach.
- Zeto: Zeto makes a wireless, dry-electrode EEG headset with cloud-based review and AI seizure-detection features. It is an emerging player offering a portable, easy-to-deploy EEG platform targeting similar ambulatory neurology and seizure-monitoring workflows as Novela.
Broad incumbents
- Ceribell: Ceribell makes the point-of-care cloud-linked EEG system used in hospitals for rapid seizure and neurological-status assessment. It is a broader neuro-monitoring incumbent whose AI-enabled EEG platform competes with Novela for neurologist mindshare, especially in the inpatient-adjacent segments.
- Natus Medical: Natus manufactures a wide range of neurodiagnostic equipment, including EEG systems used in epilepsy evaluation. As an established neurodiagnostic incumbent, it represents the legacy-channel competitor that Novela must displace or partner with to reach neurology customers.
- Masimo: Masimo offers patient-monitoring and connectivity solutions (including SedLine brain monitoring and hospital-wide monitoring platforms). While broader than epilepsy, Masimo represents the convergence of wearable sensors, AI signal processing, and clinical decision support that Novela's platform aspires to in neurology.
- Medtronic: Medtronic's Brain Therapies division includes deep brain stimulation and intraoperative/neuro monitoring products touching the epilepsy and neurology ecosystem. As a large medtech incumbent, it is a credible acquirer or channel partner and shapes pricing dynamics for novel neurology devices.
Market position
Customer concentration
Novela Neurotech social profiles
Digital presenceNovela Neurotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novela Neurotech leadership team
Management profileNumber of profiles
Profiles2 records
Novela Neurotech funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novela Neurotech M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novela Neurotech
What does Novela Neurotech do?
Novela Neurotech develops and operates the Neureka® epilepsy care platform, which delivers continuous seizure monitoring and diagnostic support using FDA-cleared wearable technology. The company sells the SeizureLink™ wearable and the SPEAC® System—both acquired through the 2022 Brain Sentinel IP acquisition—as integrated components of its platform for epilepsy diagnosis and seizure detection.
Is Novela Neurotech a public or private company?
Novela Neurotech is a private company. It is classified as unknown and is currently operating.
When was Novela Neurotech founded?
Novela Neurotech was founded in 2018. It employs 1 to 10 people.
Where is Novela Neurotech based?
Novela Neurotech is headquartered in San Francisco, United States, in the North America region.
Who are Novela Neurotech's main competitors?
Direct peers on record are Empatica and NeuroPace. Emerging players are Epitel, UNEEG Medical, iMediSync and Zeto. Broad incumbents are Ceribell, Natus Medical, Masimo and Medtronic.
Does Novela Neurotech have an API?
No public API is recorded for Novela Neurotech.
What industry is Novela Neurotech in?
Novela Neurotech's product category is Epilepsy Care Technology. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.